$1.08 Billion is the total value of Vivo Capital, LLC's 42 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 23.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | Soleno Therapeutics Inc | $298,527,521 | -17.1% | 7,316,851 | -13.1% | 27.58% | -2.6% | |
| GERN | Geron Corp | $115,435,238 | +28.5% | 27,225,292 | 0.0% | 10.66% | +51.0% | |
| HRMY | Harmony Biosciences Holdings Inc | $78,630,472 | -10.2% | 2,606,247 | 0.0% | 7.26% | +5.6% | |
| SVA | Sinovac Biotech Ltd. | $76,346,000 | 0.0% | 11,800,000 | 0.0% | 7.05% | +17.6% | |
| DYN | Dyne Therapeutics Inc | $57,703,949 | +24.3% | 1,635,136 | 0.0% | 5.33% | +46.1% | |
| AVDL | Avadel Pharmaceuticals PLCadr | $55,847,712 | -16.8% | 3,972,099 | 0.0% | 5.16% | -2.1% | |
| VRNA | Sell | Verona Pharma PLCsponsored ads | $51,329,501 | -11.6% | 3,549,758 | -1.7% | 4.74% | +3.9% |
| TERN | Sell | Terns Pharmaceuticals Inc | $42,106,176 | -3.6% | 6,182,992 | -7.1% | 3.89% | +13.3% |
| ALXO | ALX Oncology Holdings Inc | $25,446,889 | -45.9% | 4,220,048 | 0.0% | 2.35% | -36.4% | |
| VRDN | Viridian Therapeutics Inc | $21,833,473 | -25.7% | 1,678,207 | 0.0% | 2.02% | -12.6% | |
| Astria Therapeutics Inc | $21,194,146 | -35.3% | 2,329,027 | 0.0% | 1.96% | -24.0% | ||
| SLN | Silence Therapeutics PLCads | $21,003,626 | -12.0% | 1,105,454 | 0.0% | 1.94% | +3.4% | |
| OLMA | Olema Pharmaceuticals Inc | $20,273,477 | -4.4% | 1,873,704 | 0.0% | 1.87% | +12.4% | |
| COGT | Cogent Biosciences Inc | $18,924,853 | +25.4% | 2,244,941 | 0.0% | 1.75% | +47.5% | |
| New | Erasca Inc | $15,945,944 | – | 6,756,756 | +100.0% | 1.47% | – | |
| TARS | Tarsus Pharmaceuticals Inc | $15,371,649 | -25.2% | 565,550 | 0.0% | 1.42% | -12.1% | |
| DCTH | Delcath Systems, Inc. | $13,950,664 | +75.5% | 1,666,746 | 0.0% | 1.29% | +106.2% | |
| RZLT | Rezolute Inc | $12,030,127 | +68.6% | 2,797,704 | 0.0% | 1.11% | +98.0% | |
| CELC | New | Celcuity Inc | $9,999,990 | – | 610,500 | +100.0% | 0.92% | – |
| Sera Prognostics Inc | $9,770,605 | -34.9% | 1,650,440 | 0.0% | 0.90% | -23.5% | ||
| CMPS | Compass Pathway PLCsponsored ads | $9,712,320 | -27.4% | 1,608,000 | 0.0% | 0.90% | -14.7% | |
| ZLAB | Zai Lab Ltdadr | $9,205,661 | +8.2% | 531,198 | 0.0% | 0.85% | +27.1% | |
| ORIC | Buy | Oric Pharmaceuticals Inc | $8,976,609 | -23.2% | 1,269,676 | +49.4% | 0.83% | -9.7% |
| Regulus Therapeutics Inc | $8,925,000 | -38.0% | 5,000,000 | 0.0% | 0.82% | -27.2% | ||
| New | Abeona Therapeutics, Inc. | $7,813,264 | – | 1,842,751 | +100.0% | 0.72% | – | |
| Tourmaline Bio Inc. | $7,611,603 | -43.8% | 591,882 | 0.0% | 0.70% | -34.0% | ||
| New | Corbus Pharmaceuticals Holdings | $7,547,429 | – | 166,794 | +100.0% | 0.70% | – | |
| IO Biotech Inc | $7,222,924 | -32.4% | 6,173,439 | 0.0% | 0.67% | -20.5% | ||
| Buy | Instil Bio Inc | $6,424,448 | -4.7% | 624,339 | +0.0% | 0.59% | +11.9% | |
| Engene Holdings Inc. | $6,400,188 | -44.4% | 678,705 | 0.0% | 0.59% | -34.6% | ||
| Verastem Inc | $4,584,614 | -74.7% | 1,538,461 | 0.0% | 0.42% | -70.3% | ||
| CMPX | Compass Therapeutics Inc | $3,556,023 | -49.5% | 3,556,023 | 0.0% | 0.33% | -40.7% | |
| ALLK | Allakos Inc | $2,988,000 | -20.6% | 2,988,000 | 0.0% | 0.28% | -6.8% | |
| BOLT | Bolt Therapeutics Inc | $2,640,968 | -46.4% | 3,521,291 | 0.0% | 0.24% | -37.0% | |
| Unicycive Therapeutics | $1,738,893 | -63.7% | 3,470,152 | 0.0% | 0.16% | -57.2% | ||
| ALGS | Aligos Therapeutics Inc | $1,241,461 | -64.3% | 3,547,030 | 0.0% | 0.12% | -57.9% | |
| CDXS | Codexis, Inc | $1,203,246 | -11.2% | 388,144 | 0.0% | 0.11% | +4.7% | |
| New | DBV Technologies SAsponsored ads | $1,084,904 | – | 1,354,437 | +100.0% | 0.10% | – | |
| Sell | Adverum Biotechnologies, Inc. | $833,333 | -96.1% | 833,333 | -44.4% | 0.08% | -95.4% | |
| Aadi Bioscience Inc | $743,975 | -37.6% | 509,572 | 0.0% | 0.07% | -26.6% | ||
| Sell | Q32 Bio Inc. | $369,034 | -94.1% | 20,559 | -94.4% | 0.03% | -93.1% | |
| Precision Biosciences Inc | $45,489 | -28.2% | 4,675 | 0.0% | 0.00% | -20.0% | ||
| DBVT | Exit | DBV Technologies SAsponsored ads | $0 | – | -2,708,875 | -100.0% | -0.16% | – |
| SVRA | Exit | Savara Inc | $0 | – | -2,088,323 | -100.0% | -0.82% | – |
| Exit | Genetron Holdings Ltdads | $0 | – | -2,708,056 | -100.0% | -0.86% | – | |
| CRNX | Exit | Crinetics Pharmaceuticals Inc | $0 | – | -350,000 | -100.0% | -1.29% | – |
| ALPN | Exit | Alpine Immune Sciences Inc | $0 | – | -520,505 | -100.0% | -1.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CODEXIS INC | 32 | Q2 2024 | 8.0% |
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| Verona Pharma PLC ADR | 27 | Q2 2024 | 7.6% |
| KALVISTA PHARMACEUTICALS INC | 26 | Q4 2023 | 3.9% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| Zai Lab Ltd ADR | 25 | Q2 2024 | 1.8% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Arrowhead Pharmaceuticals Inc | 22 | Q4 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 22 | Q4 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.